Board & Officers

The ASGCT Board of Directors and the Society's officers have full responsibility for the management, direction and control of the business, policies and affairs of ASGCT, subject only to limitations set forth in the Society's Articles of Incorporation and Bylaws. Learn more about the Board and Officers below.

Jeffrey Chamberlain, PhD, President (2023-2024)

Paula Cannon, PhD, President Elect

Terence R. Flotte, MD, Vice President (2023-2026)

Isabelle Riviere, PhD, Secretary

Federico Mingozzi, PhD, Treasurer

Aravind Asokan, PhD

Hildegard Büning, PhD

Lindsey George, MD

Rayne Rouce, MD

Jennifer Wellman, MS, Membership Council Chair

Maria-Grazia Roncarolo, MD, Clinical & Translational Council Chair

Punam Malik, MD, Science + Education Council Chair

Daniel E. Bauer, MD, PhD

Kah-Whye Peng, PhD

Roland W. Herzog, PhD, Ex-Officio

Hans-Peter Kiem, MD, PhD, Immediate Past President

2016 Strategic Plan

In order to better meet the increasing needs of our different constituencies, ASGCT embarked on a strategic planning summit in 2015. Learn more about the five goals of the Society. 


Read the full Society Bylaws, which were amended and restated in May 2017. 


Register for the ASGCT Policy Summit

September 23-24, 2024 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.